Best Presentation
Preconference Seminar
Keynote Speakers
Submitted Abstracts
Call for Papers
Call for Posters
Contest Datasets
Important Dates
Birds of a Feather Sessions
Scientific Committee
See and Do
CAMDA 2004 Conference Call for Papers

An interdisciplinary conference dedicated to the Critical Assessment of Microarray Data Analysis, is soliciting contributions for its forth annual event on Nov 11 and 12, 2004, in Durham, North Carolina. Over the past four years, CAMDA has been a forum for the academic researchers and industry practitioners to share their research and experience in microarray data analysis. Numerous new algorithms have been reported at the CAMDA conference. To continue this tradition, this year's challenge question is threefold. 

The first part is to formulate a relevant biological question for these data. Although the microarray data will comprise the primary analysis data set, there is a wealth of additional information on the web site http://plasmodb.org. This web site integrates many kinds of data, including serial analysis of gene expression (SAGE), DNA microarrays, proteomics, as well as the complete genome sequence, a rich layer of annotation, and the results of many computational analyses.  There are rich query capabilities implemented for retreiving and analyzing the data.  On the expression view of any gene summary page there are tools for retreiving genes with similar profiles to the challenge data set.  PlasmoDB also houses other microarray data for Plasmodium faliparum.  For example 17 experiments representing the same lifecycle as the DeRisi data, and including the extra stages Merozoite, Sporozoite, and Gametocytes, using the Scripps/GNF Malaria probe-set Array.  Early this Spring the DeRisi group will also be releasing two replicates of the 48 hour time series, on two different, but very similar strains of P. falciaprum, and on the same array as the HB3 study.  This data will be visible on PlasmoDB as soon as it is available.

The questions that you address may involve anything from improving annotation or probe development to associations in the data of a cyclical nature, such as whether there is an association between chromosomal location and temporal expression.  The second part of the challenge is to apply appropriate methods to address the question that you formulated. We're not emphasizing that the methods be novel, only that the methods beappropriate for the biological questions asked.  Of course we welcome novel methods if that is what addresses the question.  Finally of critical importance is the biological interpretation of the data.  Interpret the results of the analysis in a biologically meaningful way.

All submissions must follow these rules:

  • All abstracts submitted for presentation at CAMDA must be previously unpublished original work.
  • You will be required to sign a copyright release for the final paper for publication in the proceedings book. If we are unable to obtain a publisher or if your paper is not deemed to be of sufficient quality by the editors, your copyright will be returned to you to use for your own publication purposes.
  • You are, however, allowed to present your work at other conferences, but no other publication of your material is allowed.
  • Authors are encouraged to reference the proceedings of the past three years (Methods for Microarray Analysis, volume I,II and III, Kluwer, Boston, MA, 2001, 2002 & 2003) for the format and style of the contributions.
  • Researchers must agree to make the analytical results and procedures publicly available. The disclosure of the analytical code or executables can be either in the form of commercial software, shareware, or freeware.

Paper Submission Format:

An extended abstract is necessary for the selection process by the scientific committee. The extended abstract should include key results, figures, and tables. All paper submissions should be in the ACM template (http://www.acm.org/sigs/pubs/proceed/pubform.doc). If your abstract is not in this format your paper will not be accepted. For original research papers the abstract page limit is 5. A cover page (template in Word format) should be accompanied with the abstract submission. WE ONLY EXCEPT MICROSOFT WORD FORMAT.

The deadline for submission is July 30, 2004. All submissions should be emailed to camda@mc.duke.edu.
All authors will have an opportunity to update and revise their manuscripts after the conference. Final papers to be published in the CAMDA 2004 proceedings will be due January 15, 2005. Publication of final papers is entirely at the discretion of the editors based on quality of submission.

Presentation Format:

Accepted papers will be invited for poster or oral presentation in the CAMDA 2004 conference. The authors will be notified by September 6, 2004.

  • Poster presentation: The size of the poster board is 4 x 4 (There will not be room for your poster presentations to be larger then 4' x 4')
  • Oral presentation: The time allocated for each presentation will be 25 minutes followed by 10 minutes of questions and answers. This time limit may change based on the number of submissions.

CAMDA Paper/Presentation Guideline:

Feedback of previous CAMDA attendees indicates the need for emphasis of biological relevance in addition to the data mining methodology. The submitted contributions are encouraged to include:

  • The proposed analytical objective (problems to be solved).
  • A brief summary of the analytical effort (how to solve the problem).
  • This may include the data preprocessing tasks such as data normalization, and data extraction, data mining steps and algorithms used, as well as the evaluation criteria.
  • Interpretation of results and presentation of discoveries in a biological context.
  • This will help to present an easier framework for comparisons of different approaches.
  • Discussion of the merits, assumptions, and limitations of your approach
  • Conclusions

Questions concerning the CAMDA 2004 Call for Papers should be directed to: camda@mc.duke.edu.

Agilent BioInform BioArray News

Last modified on 04/06/2004 11:57:09

© Duke Comprehensive Cancer Center